Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
Xiaokang Zhang, Shishuo Sun, Yangna Miao, Yifan Yuan, Wanxin Zhao, Hailong Li, Xiaohuan Wei, Chao Huang, Xiaolei Hu, Bixi Wang, Heng Xu, Wei Zhang, Xiaoge Gao, Jingyuan Song, Junnian Zheng, Qing Zhang
Topics & Concepts
Prostate cancerDocetaxelMedicineCancer researchCancerImmunotherapyChimeric antigen receptorMetastasisCancer cellProstateOncologyInternal medicineCAR-T cell therapy researchProstate Cancer Treatment and ResearchImmunotherapy and Immune Responses